disappointing SP action. We hit a high of 1.44 when Cymerus was announced to the world. Now we finally have validation and the SP is still lingering around these low ranges. Why would Fuji need to do a deal when they can buy us out so cheap at These levels?
Ann: Positive 28-day Clinical Trial Data in Cohort B, page-38
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.040(14.3%) |
Mkt cap ! $43.11M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 24.0¢ | $136.0K | 544.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 446 | 1 |
View Market Depth
| Last trade - 15.59pm 20/06/2024 (20 minute delay) ? |
| CYP (ASX) Chart |